Format

Send to

Choose Destination
J Surg Oncol. 2018 Feb;117(2):245-259. doi: 10.1002/jso.24813. Epub 2017 Nov 9.

Clinical studies in CRS and HIPEC: Trials, tribulations, and future directions-A systematic review.

Author information

1
Department of Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania.
2
Section of Ovarian Cancer Surgery, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
3
Department of Surgery, Frederick Memorial Hospital, Frederick, Maryland.

Abstract

BACKGROUND:

The field of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has suffered from a lack of clinical trials to validate its expanding use.

OBJECTIVE:

To evaluate published and ongoing clinical trials seeking to better define role of CRS/HIPEC in the treatment of peritoneal surface malignancies.

METHODS:

Systematic review by PubMed search was performed using terms "Clinical trial," "intraperitoneal chemotherapy," and "HIPEC." ClinicalTrials.gov and EudraCT registries were searched for active clinical trials. Eligibility included CRS/HIPEC trials investigating adult patient populations from published clinical reports and/or trials currently accruing or at completion.

RESULTS:

Thirteen published trials and 57 active clinical trials were included for review.

CONCLUSIONS:

Published and ongoing U.S. and international clinical trials for CRS and HIPEC are defining important parameters that include improving patient selection, strategic sequences of treatment, cytoreductive strategies, chemotherapeutics, optimal hyperthermic temperature and timing, and toxicity profiles. Main barriers or limitations to trial development remain patient enrollment, trial design, and oncologic community collaboration. Overall progress is positive with increasing number of clinical trials throughout the world. Collaboration between surgeons and the wider oncologic community will be crucial to validate this important treatment strategy.

KEYWORDS:

HIPEC; clinical trials; cytoreductive surgery; peritoneal carcinomatosis; peritoneal metastasis

PMID:
29120491
PMCID:
PMC6692902
DOI:
10.1002/jso.24813
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center